¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"posterior group of aphasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mixed aphasia
    È¥ÇÕ¾ð¾î»ó½ÇÁõ, È¥ÇսǾîÁõ
  • motor aphasia
    ¿îµ¿¾ð¾î»ó½ÇÁõ, ¿îµ¿½Ç¾îÁõ
  • nominal aphasia
    ¸íξð¾î»ó½ÇÁõ, ¸íĪ½Ç¾îÁõ
  • optic aphasia
    ½Ã°¢¾ð¾î»ó½ÇÁõ, ½Ã°¢½Ç¾îÁõ
  • receptive aphasia
    ¼ö¿ë¼º¾ð¾î»ó½ÇÁõ, ¼ö¿ë¼º½Ç¾îÁõ
  • syntactical aphasia
    ¹®Àå¾ð¾î»ó½ÇÁõ, ¹®Àå½Ç¾îÁõ
  • semantic aphasia
    ¸»¶æ¸ð¸§¾ð¾î»ó½ÇÁõ, ¸»¶æ¸ð¸§½Ç¾îÁõ, ¾îÀǽǾîÁõ
  • sensory aphasia
    °¨°¢¾ð¾î»ó½ÇÁõ, °¨°¢½Ç¾îÁõ
  • tactile aphasia
    Ã˰¢¾ð¾î»ó½ÇÁõ, Ã˰¢½Ç¾îÁõ
  • verbal aphasia
    ¿îµ¿¾ð¾î»ó½ÇÁõ, ¿îµ¿½Ç¾îÁõ
  • visual aphasia
    ½Ã°¢¾ð¾î»ó½ÇÁõ, ½Ã°¢½Ç¾îÁõ
  • Wernicke¡¯s aphasia
    º£¸£´ÏÄɾð¾î»ó½ÇÁõ, º£¸£´ÏÄɽǾîÁõ
  • atomic group
    ¿øÀÚ´Ü
  • ABO blood group system
    ABOÇ÷¾×Çüü°è
  • amino group
    ¾Æ¹Ì³ë±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group system
    ¿¡À̺ñ¿ÀÇ÷¾×Çü±º
  • amino group
    ¾Æ¹Ì³ë±â
  • atomic group
    ¿øÀÚ´Ü
  • group antigen
    ±ºÇ׿ø
  • group audiometry
    Áý´Üû·Â°Ë»ç
  • group-specific antigen
    ±ºÆ¯ÀÌÇ׿ø
  • basic food group
    ±âÃʽÄǰ±º
  • blood group
    Ç÷¾×Çü
  • blood group incompatibility
    Ç÷¾×ÇüºÎÀûÇÕ
  • blood group system
    Ç÷¾×Çü±º
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • borderline group
    °æ°è±º
  • coliform group
    ´ëÀå±Õ±º
  • complementation group
    »óº¸¼ºÁý´Ü
  • complementophil group
    º¸Ã¼Ä£È­±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • anterior sinus group
    ÀüºÎºñµ¿±º
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ).
  • green or yellow vegetable group
    ³ìȲ»öä¼Ò·ù.
  • group
    ±º
  • group I fiber
    Á¦¥°¤Çí·A(ð¯ìéÏØàéë«).
  • group I fiber
    Á¦¥°±º¼¶À¯(ð¯ìéÏØàéë«).
  • group II fiber
    Á¦¥±¤Çí·A.
  • group II fiber
    Á¦¥± ±º¼¶À¯(ÏØàéë«).
  • group III fiber
    Á¦¥²¤Çí·A.
  • group III fiber
    Á¦¥²±º¼¶À¯(ÏØàéë«).
  • group IV fiber
    Á¦¥³¤Çí·A.
  • group IV fiber
    Á¦¥³±º¼¶À¯(ÏØàéë«).
  • group Ia inhibition
    ¥°a¤ÇϹA.
  • group Ia inhibition
    ¥°a±º¾ïÁ¦(ÏØàéë«).
  • group antigen
    ±ºÇ׿ø(ÏØù÷ê«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • executive aphasia
    ½ÇÇ༺ ½Ç¾îÁõ(¡­ã÷åÞñø).
  • frontocortical aphasia
    ÀüµÎ¿±ÇÇÁú¼º ½Ç¾îÁõ(îñÔéç¨ù«òõàõã÷åÞñø).
  • frontolenticular aphasia
    ¿îµ¿ÁßÃß¼º ½Ç¾îÁõ(ê¡ÔÑñéõÒàõã÷åÞñø), ÀüµÎ·»ÁîÇÙ ¼º ½Ç¾îÁõ.
  • functional aphasia
    ±â´É¼º ½Ç¾î(Áõ).
  • global aphasia
    Àü½Ç¾îÁõ
  • global aphasia
    Àü½Ç¾îÁõ(îïã÷åÞñø).
  • graphomotor aphasia
    ¼­Àڿ¼º ½Ç¾îÁõ(ßöí®ê¡ÔÑàõã÷åÞñø).
  • hereditary aphasia
    À¯Àü(¼º) ½Ç¾î(Áõ).
  • intellectual aphasia
    Áö´ÉÀû ½Ç¾îÁõ
  • jargon aphasia
    Âø°¢¼º ½Ç¾î(Áõ)(ó¹ÊÆàõã÷åÞñø).
  • lenticular aphasia
    ·»ÁîÇÙ¼º ½Ç¾îÁõ(¡­ã÷åÞñø).
  • lethica aphasia
    °Ç¸Á¼º ½Ç¾îÁõ(¡­ã÷åÞñø).
  • mixed aphasia
    È¥ÇÕ¼º ½Ç¾îÁõ(¡­àõã÷åÞñø).
  • mixed aphasia
    È¥ÇÕ¼º ½Ç¾îÁõ(¡­àõã÷åÞñø).
  • monosensory aphasia
    ÀÏÁö°¢¼º ½Ç¾îÁõ(ìéò±ÊÆàõã÷åÞñø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Posterior auricular vein
    µÚ±Ó¹ÙÄûÁ¤¸Æ
    [¿¾ ¿ë¾î] ÈÄÀ̰³Á¤¸Æ
  • Posterior column
    µÚ±âµÕ [µÞ»Ô]
    [¿¾ ¿ë¾î] ÈÄÁÖ
  • Posterior cardinal vein
    µÚ±âº»Á¤¸Æ
    [¿¾ ¿ë¾î] ÈÄÁÖÁ¤¸Æ
  • Posterior deep temporal artery
    µÚ±íÀº°üÀÚµ¿¸Æ
    [¿¾ ¿ë¾î] ÈĽÉÃøµÎÁö
  • Posterior papillary muscle
    µÚ²ÀÁö±Ù
    [¿¾ ¿ë¾î] ÈÄÀ¯µÎ±Ù
  • Posterior femoral cutaneous nerve
    µÚ³Ò´Ù¸®ÇǺνŰæ
    [¿¾ ¿ë¾î] ÈÄ´ëÅðÇǽŰæ
  • Posterior meningeal artery
    µÚ³ú¸·µ¿¸Æ
    [¿¾ ¿ë¾î] Èİ渷µ¿¸Æ
  • Posterior paraventricular nucleus
    µÚ³ú½Ç°çÇÙ
    [¿¾ ¿ë¾î] ÈĽǹæÇÙ
  • Posterior perivenricular nucleus
    µÚ³ú½ÇÁÖÀ§ÇÙ
    [¿¾ ¿ë¾î] ÈĽǹæÇÙ
  • Posterior lacrimal crest
    µÚ´«¹°´É¼±
    [¿¾ ¿ë¾î] Èĵγ¶¸ª
  • Posterior cochlear nucleus
    µÚ´ÞÆØÀÌÇÙ
    [¿¾ ¿ë¾î] ÈĿͿì½Å°æÇÙ
  • Posterior cerebral a.
    µÚ´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄ´ë³úµ¿¸Æ
  • Posterior cerebral artery
    µÚ´ë³úµ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄ´ë³úµ¿¸Æ
  • Posterior accessory olivary nucleus
    µÚµ¡¿Ã¸®ºêÇÙ
    [¿¾ ¿ë¾î] Èĺοø®ºêÇÙ
  • Posterior process of septal nasal cartilage
    µÚµ¹±â
    [¿¾ ¿ë¾î] Èĵ¹±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hypsochromic group
    û»öÀ̵¿±â(ôìßäì¹ÔÑÐñ)
  • imidazole group
    À̴̹ÙÁ¹±â(Ðñ)
  • imino group
    À̹̳ë±â(Ðñ)
  • Inv group
    Inv ±º(ÏØ)
  • ketone group
    ÄÉÅæ±â(Ðñ)
  • labile methyl group
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ)¸ÞÆ¿±â(Ðñ)
  • labile phosphate group
    ºÒ¾ÈÁ¤Àλê±â(ÝÕäÌïÒ×ò߫Ѩ)
  • leaving group
    ÀÌÅ»±â(×î÷­Ðñ)
  • linkage group
    ¿¬°ü±º(Ö¤Î¼ÏØ)
  • mercapto group
    ¸Ó°©Åä±â(Ðñ)
  • methenyl group
    ¸ÞÅ×´Ò±â(Ðñ)
  • methylene group
    ¸ÞÆ¿·»±â(Ðñ)
  • methyl group
    ¸ÞÆ¿±â(Ðñ)
  • MN blood group system
    MN½Ä(ãÒ)Ç÷¾×Çü(úìäûúþ)
  • neighboring group effect
    ±ÙÁ¢±â È¿°ú(ÐÎïÈÐïüùÍý)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
AAT Aachen Aphasia Test; academic aptitude test; alanine aminotransferase; alkylating agent therapy; alp...
ALPS angiolymphoproliferative syndrome; Aphasia Language Performance Scale; attitudinal listening profile...
Aph aphasia
AQ achievement quotient; any quantity; aphasia quotient
BASA Boston Assessment of Severe Aphasia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
Group III group
APMPPE Acute Posterior Multifocal Placoid Pigment Epitheliopathy
LVPW Left Ventricular Posterior Wall
P Posterior
PO Posterior
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • semantic aphasia
    ¹®ÀÇ ½Ç¾î, ¹®ÀÇ ½Ç¾îÁõ, ¾îÀÇ ½Ç¾î
    ´Ü¾î¿Í ¾î±¸ÀÇ ¶æÀ» ¸ð¸£°Å³ª ȤÀº ±â¾ïÇÏÁö ¸øÇÏ´Â ½Ç¾î.
  • syntactical aphasia
    ¹®Àå ½Ç¾î
    ¾ð¾î¸¦ ÀûÀýÈ÷ ¹è¿­ÇÏÁö ¸øÇÏ´Â ½Ç¾îÁõ. µû¶ó¼­ ȯÀڴ Ⱦ¼³¼ö¼³ÇÏ°Ô µÈ´Ù.
  • tactile aphasia
    Ã˰¢ ½Ç¾î
    ¸ö¿¡ ´ê´Â ¹°°ÇÀÇ À̸§À» ¸»ÇÏÁö ¸øÇÏ´Â °Í.
  • total aphasia
    Àü½Ç¾îÁõ
  • true aphasia
    Áø¼º ½Ç¾î
    ¾ð¾î ÁßÃß Áß ¾î¶² ÇϳªÀÇ º´º¯¿¡ ÀÇÇÑ ½Ç¾îÁõ.
  • Wernicke's aphasia
    º£¸£´ÏÄÉ ½Ç¾îÁõ
  • angulus posterior pyramidis ossis parietalis
    ÃøµÎ°ñ Ãßü Èİ¢
    ÃøµÎ°ñÀÇ ÃßüºÎ À§ÀÇ °¢À¸·Î¼­ Èĸé°ú ÇϸéÀ¸·Î ³ª´©¾îÁø´Ù.
  • apical posterior segment
    ÈÄ¹æ Æó÷
  • arcus posterior
    µÚ±Ã, ÈıÃ
  • arteria alveolaris superior posterior
    µÚÀ§ ÀÌÆ² µ¿¸Æ, ÈÄ»ó Ä¡Á¶ µ¿¸Æ
    µ¿ÀǾî=
  • arteria cerebri posterior
    µÚ ´ë³ú µ¿¸Æ, ÈÄ´ë³ú µ¿¸Æ
    µ¿ÀǾî=
  • arteria circumflexa humeri posterior
    ÈÄ¹æ »ó¿Ï ȸ¼± µ¿¸Æ
    ¾×¿Í µ¿¸Æ¿¡¼­ ±â¿øÇÏ¿´À¸¸ç ºÐÁö¸¦ ³»Áö ¾Ê°í »ï°¢±Ù, °ß°üÀý, ¼Ò¿ø±Ù, »ó¿Ï »ïµÎ±Ù¿¡ ºÐÆ÷ÇÏ´Â µ¿¸Æ.
  • arteria ethmoidalis posterior
    µÚ »ç°ñ µ¿¸Æ, ÈÄ»ç°ñ µ¿¸Æ
    µ¿ÀǾî=
  • arteria malleolaris fibularis posterior
    ÈÄ ºñÃø°ú µ¿¸Æ
  • arteria malleolaris tibialis posterior
    ÈÄ °æÃø°ú µ¿¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
amino group <biochemistry> An -NH2 group. Organic compounds which have this group are called amines.
(09 Oct 1997)
anterior group of axillary lymph nodes Lymph nodes located along the lateral thoracic vein; they receive the drainage of the pectoral region, including most of the drainage of the breast.
Synonym: nodi lymphatici axillaris pectorales, anterior group of axillary lymph nodes.
(05 Mar 2000)
apical group of axillary lymph nodes The group of lymph node's located at the apex of the axillary fossa that receive lymphatic drainage from other groups of axillary node's and then drain in turn into the subclavian lymphatic trunk.
Synonym: nodi lymphatici axillares apicales.
(05 Mar 2000)
Bethesda-Ballerup Group A group of citrate-utilizing, slow lactose-fermenting bacteria (family Enterobacteriaceae) which share a similar series of antigens with the lactose-fermenting citrobacters; these organisms are now included in the genus Citrobacter without a distinction between prompt and slow lactose fermentation.
(05 Mar 2000)
blood group <haematology> An inherited feature on the surface of the red blood cell. A series of related blood groups make up a blood group system such as the ABO system or the Rh system.
Erythrocytic allotypes (or phenotypes) defined by one or more cellular antigenic structural groupings under the control of allelic genes. Blood groups, especially for man, are identified by agglutinins supported by specific human or animal antisera and by lectins extracted from certain plants.
See: blood group antigen.
(25 Jun 1999)
blood group antigen <haematology, immunology> The set of cell surface antigens found chiefly, but not solely, on blood cells.
More than fifteen different blood group systems are recognised in humans. There may be naturally occurring antibodies without immunisation, especially in the case of the ABO system and matching blood groups is important for safe transfusion.
In most cases the antigenic determinant resides in the carbohydrate chains of membrane glycoproteins or glycolipids.
See: Rhesus, Duffy, Kell, Lewis and MN.
(25 Jun 1999)
blood group incompatibility A mismatch between donor and recipient blood. Antibodies present in the recipient's serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is haemolyzed.
(12 Dec 1998)
blood group substance Blood group-specific substances A and B, solution of complexes of polysaccharides and amino acids that reduces the titre of anti-A and anti-B isoagglutinins in serum from group O persons; used to render group O blood reasonably safe for transfusion into persons of group A, B, or AB, but does not affect any incompatibility that results from various other factors, such as Rh.
(05 Mar 2000)
bunyamwera group viruses A large group of viruses from many parts of the world assigned to the bunyavirus genus of the family bunyaviridae. They are transmitted by mosquitoes and infect humans in some areas. This group contains the type species of the genus, bunyamwera virus.
(12 Dec 1998)
calcium group The metals of the alkaline earths: beryllium, magnesium, calcium, strontium, barium, and radium.
(05 Mar 2000)
california group viruses A group of viruses in the bunyavirus genus of the bunyaviridae family. They are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several virus species infect humans.
(12 Dec 1998)
carbonyl group A group in which an oxygen atom is double-bonded to a carbon atom: O=C. The carbon atom then has two additional bonds to attach to the rest of the molecule. Organic molecules containing a carbonyl group are a very important, major group of compounds studied in the field of organic chemistry.
(09 Oct 1997)
carboxyl group -COOH group. One of the oxygens is double-bonded to the carbon atom, making it a carbonyl group, and the other oxygen is single bonded to the carbon on one side, and single bonded to the hydrogen on the other. The remaining bond on the carbon atom is attached to the rest of the molecule. Organic molecules containing carboxyl groups are an important, major group of compounds studied in the field of organic chemistry.
(09 Oct 1997)
vanadium group Those elements resembling vanadium in chemical and metallurgical properties; included with vanadium are niobium and tantalum.
(05 Mar 2000)
marathon group psychotherapy A type of group psychotherapy characterised by uninterrupted sessions for periods of hours or days, with minimal interruptions for food and rest.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • tail group
    TAIL UNIT
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á